ArfGAP domain-containing protein 2 (ADAP2) integrates upstream and downstream modules of RIG-I signaling and facilitates type I interferon production

Molecular and Cellular Biology

Volumn 37, Issue 6, 2017, Pages

  Bist, Pradeep ^a   Kim, Susana Soo Yeon ^a   Pulloor, Niyas Kudukil ^a   McCaffrey, Kathleen ^a,c   Nair, Sajith Kumar ^a   Liu, Yiliu ^b   Lin, Rongtuan ^b   Krishnan, Manoj N ^a  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b MCGILL UNIVERSITY   (Canada)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Innate immunity; Interferons; RIG I

Indexed keywords

ARFGAP DOMAIN CONTAINING PROTEIN 2; I KAPPA B KINASE GAMMA; INTERFERON; INTERFERON REGULATORY FACTOR 3; PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG; ADAP2 PROTEIN, HUMAN; DDX58 PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PATTERN RECOGNITION RECEPTOR; PROTEIN BINDING; RECOMBINANT PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CASPASE ACTIVATION AND RECRUITMENT DOMAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENDAI VIRUS; SIGNAL TRANSDUCTION; VESICULOVIRUS; VIRUS INFECTION; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL FRACTIONATION; CELL FREE SYSTEM; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN DOMAIN;

CELL-FREE SYSTEM; DEAD BOX PROTEIN 58; GTPASE-ACTIVATING PROTEINS; HEK293 CELLS; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; MODELS, BIOLOGICAL; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN DOMAINS; RECEPTORS, PATTERN RECOGNITION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TRANSCRIPTION, GENETIC; VESICULOVIRUS;

EID: 85014415224     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00537-16     Document Type: Article

References (74)

1. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW. 2010. Dengue: a continuing global threat. Nat Rev Microbiol 8:S7-S16. https://doi.org/10.1038/nrmicro2460.
2. Morens DM, Fauci AS. 2012. Emerging infectious diseases in 2012: 20 years after the Institute of Medicine report. mBio 3:e00494-12. https://doi.org/10.1128/mBio.00494-12.
3. Kumagai Y, Akira S. 2010. Identification and functions of patternrecognition receptors. J Allergy Clin Immunol 125:985-992. https://doi.org/10.1016/j.jaci.2010.01.058.
4. Kumar H, Kawai T, Akira S. 2009. Pathogen recognition in the innate immune response. Biochem J 420:1-16. https://doi.org/10.1042/BJ20090272.
5. Patel JR, Garcia-Sastre A. 2014. Activation and regulation of pathogen sensor RIG-I. Cytokine Growth Factor Rev 25:513-523. https://doi.org/10.1016/j.cytogfr.2014.08.005.
6. Ramos HJ, Gale M, Jr. 2011. RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr Opin Virol 1:167-176. https://doi.org/10.1016/j.coviro.2011.04.004.
7. Seth RB, Sun L, Chen ZJ. 2006. Antiviral innate immunity pathways. Cell Res 16:141-147. https://doi.org/10.1038/sj.cr.7310019.
8. Yan N, Chen ZJ. 2012. Intrinsic antiviral immunity. Nat Immunol 13: 214-222. https://doi.org/10.1038/ni.2229.
9. Yoneyama M, Fujita T. 2010. Recognition of viral nucleic acids in innate immunity. Rev Med Virol 20:4-22. https://doi.org/10.1002/rmv.633.
10. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6:975-990. https://doi.org/10.1038/nrd2422.
11. Garcia-Sastre A, Biron CA. 2006. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312:879-882. https://doi.org/10.1126/science.1125676.
12. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1:519-525. https://doi.org/10.1016/j.coviro.2011.10.008.
13. Stetson DB, Medzhitov R. 2006. Type I interferons in host defense. Immunity 25:373-381. https://doi.org/10.1016/j.immuni.2006.08.007.
14. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, Bier K, Robb N, Vreede F, Barclay W, Fodor E, Reis e Sousa C. 2010. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140: 397-408. https://doi.org/10.1016/j.cell.2010.01.020.
15. Takeuchi O, Akira S. 2008. MDA5/RIG-I and virus recognition. Curr Opin Immunol 20:17-22. https://doi.org/10.1016/j.coi.2008.01.002.
16. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737. https://doi.org/10.1038/ni1087.
17. Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141:668-681. https://doi.org/10.1016/j.cell.2010.04.018.
18. Horner SM, Liu HM, Park HS, Briley J, Gale M, Jr. 2011. Mitochondrialassociated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci U S A 108:14590-14595. https://doi.org/10.1073/pnas.1110133108.
19. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 6:981-988. https://doi.org/10.1038/ni1243.
20. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172. https://doi.org/10.1038/nature04193.
21. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NFkappaB and IRF 3. Cell 122:669-682. https://doi.org/10.1016/j.cell.2005.08.012.
22. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19: 727-740. https://doi.org/10.1016/j.molcel.2005.08.014.
23. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146:448-461. https://doi.org/10.1016/j.cell.2011.06.041.
24. Xu H, He X, Zheng H, Huang LJ, Hou F, Yu Z, de la Cruz MJ, Borkowski B, Zhang X, Chen ZJ, Jiang QX. 2014. Structural basis for the prion-like MAVS filaments in antiviral innate immunity. eLife 3:e01489. https://doi.org/10.7554/eLife.01489.
25. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491-496.
26. Hiscott J. 2007. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev 18:483-490. https://doi.org/10.1016/j.cytogfr.2007.06.002.
27. Hiscott J, Pitha P, Genin P, Nguyen H, Heylbroeck C, Mamane Y, Algarte M, Lin R. 1999. Triggering the interferon response: the role of IRF-3 transcription factor. J Interferon Cytokine Res 19:1-13. https://doi.org/10.1089/107999099314360.
28. Servant MJ, Grandvaux N, Hiscott J. 2002. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem Pharmacol 64:985-992. https://doi.org/10.1016/S0006-2952(02)01165-6.
29. Lin R, Heylbroeck C, Pitha PM, Hiscott J. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18:2986-2996. https://doi.org/10.1128/MCB.18.5.2986.
30. Lin R, Mamane Y, Hiscott J. 1999. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol 19:2465-2474. https://doi.org/10.1128/MCB.19.4.2465.
31. Panne D, McWhirter SM, Maniatis T, Harrison SC. 2007. Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J Biol Chem 282:22816-22822. https://doi.org/10.1074/jbc.M703019200.
32. Suhara W, Yoneyama M, Iwamura T, Yoshimura S, Tamura K, Namiki H, Aimoto S, Fujita T. 2000. Analyses of virus-induced homomeric and heteromeric protein associations between IRF-3 and coactivator CBP/p300. J Biochem 128:301-307. https://doi.org/10.1093/oxfordjournals.jbchem.a022753.
33. Takahasi K, Horiuchi M, Fujii K, Nakamura S, Noda NN, Yoneyama M, Fujita T, Inagaki F. 2010. Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP/p300 without overall conformational change. Genes Cells 15:901-910. https://doi.org/10.1111/j.1365-2443.2010.01427.x.
34. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1:507-518. https://doi.org/10.1016/S1097-2765(00)80051-9.
35. Jacobs JL, Coyne CB. 2013. Mechanisms of MAVS regulation at the mitochondrial membrane. J Mol Biol 425:5009-5019. https://doi.org/10.1016/j.jmb.2013.10.007.
36. Liu S, Chen J, Cai X, Wu J, Chen X, Wu YT, Sun L, Chen ZJ. 2013. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. eLife 2:e00785. https://doi.org/10.7554/eLife.00785.
37. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-678. https://doi.org/10.1038/nature07317.
38. Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-791. https://doi.org/10.1126/science.1232458.
39. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, Lei C, He X, Zhang L, Tien P, Shu HB. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538-550. https://doi.org/10.1016/j.immuni.2008.09.003.
40. Liu XY, Chen W, Wei B, Shan YF, Wang C. 2011. IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1. J Immunol 187:2559-2568. https://doi.org/10.4049/jimmunol.1100963.
41. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920. https://doi.org/10.1038/nature05732.
42. Nakhaei P, Mesplede T, Solis M, Sun Q, Zhao T, Yang L, Chuang TH, Ware CF, Lin R, Hiscott J. 2009. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog 5:e1000650. https://doi.org/10.1371/journal.ppat.1000650.
43. Oshiumi H, Miyashita M, Inoue N, Okabe M, Matsumoto M, Seya T. 2010. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 8:496-509. https://doi.org/10.1016/j.chom.2010.11.008.
44. Zeng W, Xu M, Liu S, Sun L, Chen ZJ. 2009. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol Cell 36:315-325. https://doi.org/10.1016/j.molcel.2009.09.037.
45. Zhao T, Yang L, Sun Q, Arguello M, Ballard DW, Hiscott J, Lin R. 2007. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol 8:592-600. https://doi.org/10.1038/ni1465.
46. Li S, Wang L, Berman M, Kong YY, Dorf ME. 2011. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35:426-440. https://doi.org/10.1016/j.immuni.2011.06.014.
47. Mao AP, Li S, Zhong B, Li Y, Yan J, Li Q, Teng C, Shu HB. 2010. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. J Biol Chem 285:9470-9476. https://doi.org/10.1074/jbc.M109.071043.
48. Saha SK, Pietras EM, He JQ, Kang JR, Liu SY, Oganesyan G, Shahangian A, Zarnegar B, Shiba TL, Wang Y, Cheng G. 2006. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J 25:3257-3263. https://doi.org/10.1038/sj.emboj.7601220.
49. Tang ED, Wang CY. 2010. TRAF5 is a downstream target of MAVS in antiviral innate immune signaling. PLoS One 5:e9172. https://doi.org/10.1371/journal.pone.0009172.
50. Zhou Z, Jia X, Xue Q, Dou Z, Ma Y, Zhao Z, Jiang Z, He B, Jin Q, Wang J. 2014. TRIM14 is a mitochondrial adaptor that facilitates retinoic acidinducible gene-I-like receptor-mediated innate immune response. Proc Natl Acad Sci U S A 111:E245-E254. https://doi.org/10.1073/pnas.1316941111.
51. Gatot JS, Gioia R, Chau TL, Patrascu F, Warnier M, Close P, Chapelle JP, Muraille E, Brown K, Siebenlist U, Piette J, Dejardin E, Chariot A. 2007. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J Biol Chem 282:31131-31146. https://doi.org/10.1074/jbc.M701690200.
52. Guo B, Cheng G. 2007. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 282:11817-11826. https://doi.org/10.1074/jbc.M700017200.
53. Kawagoe T, Takeuchi O, Takabatake Y, Kato H, Isaka Y, Tsujimura T, Akira S. 2009. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat Immunol 10:965-972. https://doi.org/10.1038/ni.1771.
54. Liu XY, Wei B, Shi HX, Shan YF, Wang C. 2010. Tom70 mediates activation of interferon regulatory factor 3 on mitochondria. Cell Res 20:994-1011. https://doi.org/10.1038/cr.2010.103.
55. Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, Du F, Ren J, Wu YT, Grishin NV, Chen ZJ. 2015. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347:aaa2630. https://doi.org/10.1126/science.aaa2630.
56. Chau TL, Gioia R, Gatot JS, Patrascu F, Carpentier I, Chapelle JP, O'Neill L, Beyaert R, Piette J, Chariot A. 2008. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem Sci 33: 171-180. https://doi.org/10.1016/j.tibs.2008.01.002.
57. Fujita F, Taniguchi Y, Kato T, Narita Y, Furuya A, Ogawa T, Sakurai H, Joh T, Itoh M, Delhase M, Karin M, Nakanishi M. 2003. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol Cell Biol 23:7780-7793. https://doi.org/10.1128/MCB.23.21.7780-7793.2003.
58. Ryzhakov G, Randow F. 2007. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J 26:3180-3190. https://doi.org/10.1038/sj.emboj.7601743.
59. Sasai M, Oshiumi H, Matsumoto M, Inoue N, Fujita F, Nakanishi M, Seya T. 2005. Cutting edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation. J Immunol 174: 27-30. https://doi.org/10.4049/jimmunol.174.1.27.
60. Sasai M, Shingai M, Funami K, Yoneyama M, Fujita T, Matsumoto M, Seya T. 2006. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J Immunol 177: 8676-8683. https://doi.org/10.4049/jimmunol.177.12.8676.
61. Pulloor NK, Nair S, Kostic AD, Bist P, Weaver JD, Riley AM, Tyagi R, Uchil PD, York JD, Snyder SH, Garcia-Sastre A, Potter BV, Lin R, Shears SB, Xavier RJ, Krishnan MN. 2014. Human genome-wide RNAi screen identifies an essential role for inositol pyrophosphates in type-I interferon response. PLoS Pathog 10:e1003981. https://doi.org/10.1371/journal.ppat.1003981.
62. Fenner BJ, Scannell M, Prehn JH. 2010. Expanding the substantial interactome of NEMO using protein microarrays. PLoS One 5:e8799. https://doi.org/10.1371/journal.pone.0008799.
63. Li Y, Xie J, Wu S, Xia J, Zhang P, Liu C, Zhang P, Huang X. 2013. Protein kinase regulated by dsRNA downregulates the interferon production in dengue virus-and dsRNA-stimulated human lung epithelial cells. PLoS One 8:e55108. https://doi.org/10.1371/journal.pone.0055108.
64. Hanck T, Stricker R, Sedehizade F, Reiser G. 2004. Identification of gene structure and subcellular localization of human centaurin alpha 2, and p42IP4, a family of two highly homologous, Ins 1, 3, 4, 5-P4-/PtdIns 3, 4, 5-P3-binding, adapter proteins. J Neurochem 88:326-336.
65. Kahn RA, Bruford E, Inoue H, Logsdon JM, Jr, Nie Z, Premont RT, Randazzo PA, Satake M, Theibert AB, Zapp ML, Cassel D. 2008. Consensus nomenclature for the human ArfGAP domain-containing proteins. J Cell Biol 182:1039-1044. https://doi.org/10.1083/jcb.200806041.
66. Whitley P, Gibbard AM, Koumanov F, Oldfield S, Kilgour EE, Prestwich GD, Holman GD. 2002. Identification of centaurin-alpha2: a phosphatidylinositide-binding protein present in fat, heart and skeletal muscle. Eur J Cell Biol 81:222-230. https://doi.org/10.1078/0171-9335-00242.
67. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. https://doi.org/10.1038/nature04734.
68. Randazzo PA, Inoue H, Bharti S. 2007. Arf GAPs as regulators of the actin cytoskeleton. Biol Cell 99:583-600. https://doi.org/10.1042/BC20070034.
69. Yamamoto-Furusho JK, Barnich N, Xavier R, Hisamatsu T, Podolsky DK. 2006. Centaurin beta1 down-regulates nucleotide-binding oligomerization domains 1-and 2-dependent NF-kappaB activation. J Biol Chem 281:36060-36070. https://doi.org/10.1074/jbc.M602383200.
70. Venturin M, Carra S, Gaudenzi G, Brunelli S, Gallo GR, Moncini S, Cotelli F, Riva P. 2014. ADAP2 in heart development: a candidate gene for the occurrence of cardiovascular malformations in NF1 microdeletion syndrome. J Med Genet 51:436-443. https://doi.org/10.1136/jmedgenet-2013-102240.
71. Zuccotti P, Cartelli D, Stroppi M, Pandini V, Venturin M, Aliverti A, Battaglioli E, Cappelletti G, Riva P. 2012. Centaurin-alpha(2) interacts with beta-tubulin and stabilizes microtubules. PLoS One 7:e52867. https://doi.org/10.1371/journal.pone.0052867.
72. Paz S, Vilasco M, Werden SJ, Arguello M, Joseph-Pillai D, Zhao T, Nguyen TL, Sun Q, Meurs EF, Lin R, Hiscott J. 2011. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res 21:895-910. https://doi.org/10.1038/cr.2011.2.
73. Ikeda F, Hecker CM, Rozenknop A, Nordmeier RD, Rogov V, Hofmann K, Akira S, Dotsch V, Dikic I. 2007. Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. EMBO J 26:3451-3462. https://doi.org/10.1038/sj.emboj.7601773.
74. Wang L, Li S, Dorf ME. 2012. NEMO binds ubiquitinated TANK-binding kinase 1 (TBK1) to regulate innate immune responses to RNA viruses. PLoS One 7:e43756. https://doi.org/10.1371/journal.pone.0043756.